Symbol="TCBP"
AssetType="Common Stock"
Name="TC BioPharm Holdings PLC"
Description="TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, is focused on developing immunotherapy products based on its gamma delta allogeneic T-cell platform. The company is headquartered in Motherwell, the United Kingdom."
CIK="1872812"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="MAXIM 1, 2 PARKLANDS WAY, HOLYTOWN, GB"
FiscalYearEnd="December"
LatestQuarter="2022-06-30"
MarketCapitalization="2144000"
EBITDA="-11158647"
PERatio="None"
PEGRatio="None"
BookValue="-0.027"
DividendPerShare="0"
DividendYield="0"
EPS="-2.06"
RevenuePerShareTTM="5.59"
ProfitMargin="-0.361"
OperatingMarginTTM="-3.101"
ReturnOnAssetsTTM="-0.785"
ReturnOnEquityTTM="0"
RevenueTTM="3844500"
GrossProfitTTM="3844500"
DilutedEPSTTM="-2.06"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.886"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="84.97"
PriceToBookRatio="137.08"
EVToRevenue="84.78"
EVToEBITDA="-85.23"
Beta="None"
num_52WeekHigh="22"
num_52WeekLow="0.445"
num_50DayMovingAverage="0.773"
num_200DayMovingAverage="4.74"
SharesOutstanding="4688500"
DividendDate="None"
ExDividendDate="None"
symbol="TCBP"
open="0.50"
high="0.53"
low="0.45"
price="0.46"
volume="1520686.00"
latest_trading_day="2023-07-07"
previous_close="0.49"
change="-0.03"
change_percent="-6.0214%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="76"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="24"
Volume_recent_avg="301050"
Change_recent_avg="-0.05"
Delta_recent_avg="0.29"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="-3.0"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="24"
Aroon_momentum_negative="76"
image_negative_thumbnail_id_1="1157"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0191.jpeg"
image_negative_thumbnail_id_2="507"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0098.jpeg"
image_neutral_thumbnail_id_1="585"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_neutral_thumbnail_id_2="592"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0007.jpeg"
image_positive_thumbnail_id_1="662"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0046.jpeg"
image_positive_thumbnail_id_2="1003"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0165.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
